Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hi-Tech Hunts Growth As FTC Picks Up Scent On Disputed Weight Loss Claims

This article was originally published in The Tan Sheet

Executive Summary

FTC asks a federal court to re-instate a contempt order stemming from Hi-Tech Pharmaceuticals’ misleading claims for weight loss supplements that an appellate court overturned. Hi-Tech, meanwhile, argues for recusal of the judge who found the firm in contempt and ordered two executives to jail.


Related Content

Hi-Tech CEO Wheat Arrested In FDA Investigation Of Steroid-Spiked Supplements
Hi-Tech Avoids FTC Contempt Charge, But Not The Judge
Industry News: Twinlab Into Resveratrol, Hi-Tech Buys LG Brands
Industry Roundup: FDA Inspecting McNeil Plants, Hi-Tech Gets Another Chance Against FTC
Hi-Tech Pharmaceuticals Indicted For Online “Generic” Drug Enterprise





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts